First Quadrant’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-7,024
| Closed | -$1.54M | – | 518 |
|
2021
Q4 | $1.54M | Hold |
7,024
| – | – | 0.17% | 123 |
|
2021
Q3 | $1.27M | Buy |
7,024
+2,400
| +52% | +$435K | 0.15% | 133 |
|
2021
Q2 | $932K | Sell |
4,624
-3,671
| -44% | -$740K | 0.11% | 175 |
|
2021
Q1 | $1.78M | Sell |
8,295
-5,274
| -39% | -$1.13M | 0.19% | 113 |
|
2020
Q4 | $3.21M | Sell |
13,569
-1,465
| -10% | -$346K | 0.32% | 51 |
|
2020
Q3 | $4.09M | Sell |
15,034
-2,003
| -12% | -$545K | 0.52% | 32 |
|
2020
Q2 | $4.95M | Sell |
17,037
-5,952
| -26% | -$1.73M | 0.66% | 25 |
|
2020
Q1 | $5.47M | Buy |
22,989
+11,368
| +98% | +$2.7M | 0.8% | 20 |
|
2019
Q4 | $2.54M | Sell |
11,621
-6,198
| -35% | -$1.36M | 0.21% | 102 |
|
2019
Q3 | $3.02M | Sell |
17,819
-845
| -5% | -$143K | 0.28% | 90 |
|
2019
Q2 | $3.42M | Buy |
18,664
+12,360
| +196% | +$2.27M | 0.24% | 104 |
|
2019
Q1 | $1.16M | Sell |
6,304
-878
| -12% | -$162K | 0.09% | 239 |
|
2018
Q4 | $1.19M | Sell |
7,182
-127,235
| -95% | -$21.1M | 0.1% | 214 |
|
2018
Q3 | $25.9M | Sell |
134,417
-58,510
| -30% | -$11.3M | 0.58% | 30 |
|
2018
Q2 | $32.8M | Buy |
192,927
+1,298
| +0.7% | +$221K | 0.61% | 30 |
|
2018
Q1 | $31.2M | Buy |
191,629
+55,646
| +41% | +$9.07M | 0.6% | 23 |
|
2017
Q4 | $20.4M | Buy |
135,983
+6,168
| +5% | +$924K | 0.38% | 88 |
|
2017
Q3 | $19.7M | Buy |
129,815
+127,856
| +6,527% | +$19.4M | 0.38% | 85 |
|
2017
Q2 | $252K | Buy |
1,959
+1,459
| +292% | +$188K | 0.01% | 649 |
|
2017
Q1 | $55K | Hold |
500
| – | – | ﹤0.01% | 745 |
|
2016
Q4 | $37K | Hold |
500
| – | – | ﹤0.01% | 782 |
|
2016
Q3 | $44K | Hold |
500
| – | – | ﹤0.01% | 796 |
|
2016
Q2 | $43K | Hold |
500
| – | – | ﹤0.01% | 720 |
|
2016
Q1 | $40K | Buy |
+500
| New | +$40K | ﹤0.01% | 701 |
|
2015
Q4 | – | Sell |
-400
| Closed | -$42K | – | 844 |
|
2015
Q3 | $42K | Buy |
400
+200
| +100% | +$21K | ﹤0.01% | 692 |
|
2015
Q2 | $25K | Buy |
+200
| New | +$25K | ﹤0.01% | 729 |
|